World-first Parkinson’s stem cells trial

News

Author: Simge Eva DoganPublished: 9 August 2018

Prep: Cook: Serves:

Scientists at a Japanese university will carry out a world-first clinical trial transplanting reprogrammed stem cells into the brains of seven people with Parkinson’s.

Researchers believe the process – which was tested on monkeys last year – will allow the brain to create dopamine to counter the effects of Parkinson’s.

Shinya Yamanaka, who is working on the study and won the Nobel Prize in 2012 for his work with stem cells, said: “We intend to carry on conducting our research carefully, yet expeditiously, in coordination with Kyoto University Hospital, so that new treatment will be brought to patients as soon as possible.”

Researchers are hoping to create a treatment that will be covered by national health insurance in Japan.

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Last Month

Next Month

Go Back

Share this story

Comments

Advances

EU approval for Medtronic DBS systems improves access to full-body MRI scans

Patients receiving DBS therapy have the option of full-body MRI scans

Fighting Fit: tackling Parkinson’s in the workplace

We talk to the founders of a new programme in Buckinghamshire, UK

Apple Watch to detect Parkinson’s symptoms

The tech giant announced the news at a recent technology event

Is sleepwalking linked to risk of Parkinson’s disease in men?

Men who sleepwalk may be at a greater risk of developing Parkinson’s disease, according to a new study from researchers in the US. The team assessed Mayo Clinic sleep questionnaire survey answers from 25,694 men, 1% of whom had been diagnosed with Parkinson’s disease. They found that men who experienced sleepwalking were four times more likely to have Parkinson’s, and those with probable REM sleep behaviour disorder – a condition where sleepers experience sudden body movements while dreaming – were six times more likely. For those who experienced both sleepwalking and REM sleep behaviour disorder, the risk increased to eight times more likely. “We need further studies to understand this,” said senior author, Dr Xiang Gao. “Particularly to see whether sleepwalking occurs before Parkinson’s onset, and the number of individuals with sleepwalking who eventually develop Parkinson’s and other neurodegenerative diseases.”

Stay tuned for series two of the Parkinson’s Life podcast

The award-winning Parkinson’s Life podcast is back this month. Helping to amplify the voices of the international Parkinson’s community, the podcast has so far reached more than 12,000 people around the world. Thanks to the support of pharmaceutical companies, and the backing of a grant from the Boston Scientific Foundation Europe, the second series will bring together people with Parkinson’s disease and experts in their field to explore topics such as sleep hygiene, exercise and mental health, and to offer advice to listeners. Sandrine Bazile, president of the Boston Scientific Foundation Europe, says: “We fully support this project because it mirrors perfectly our mission to improve patient wellbeing using innovative solutions. We believe in the importance of the [Parkinson’s Life] podcast series, with its aim to improve the information and education available to people with Parkinson’s and their families – to help them live life to the full.”

How Parkinson’s disease could impact the way you see art

A new study from a team at the University of Pennsylvania’s Perelman School of Medicine, US, has indicated that Parkinson’s disease could affect the way people experience art. The researchers asked 43 people with the condition and 40 controls to make judgements about 10 paintings by American artist Jackson Pollock and 10 by Dutch painter Piet Mondrian, rating them according to factors including liking, beauty, motion, complexity and colour-saturation. The participants with Parkinson’s showed more of a preference for ‘high-motion’ art. They also showed a lower recognition of movement compared to controls, suggesting that the brain’s motor system may help interpret movement from static visual cues. However, the research team noted that many of the participants were on their usual medication, and that the impact of dopamine agonists on the experience of art would also need to be considered.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

World-first Parkinson’s stem cells trial

News

Author: Simge Eva DoganPublished: 9 August 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

sponsored article

Advances

EU approval for Medtronic DBS systems improves access to full-body MRI scans

Interviews

Fighting Fit: tackling Parkinson’s in the workplace

Advances

Apple Watch to detect Parkinson’s symptoms

Is sleepwalking linked to risk of Parkinson’s disease in men?

Stay tuned for series two of the Parkinson’s Life podcast

How Parkinson’s disease could impact the way you see art

{title}

Subscribe

World-first Parkinson’s stem cells trial

News

Author: Simge Eva DoganPublished: 9 August 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

sponsored article

Advances

EU approval for Medtronic DBS systems improves access to full-body MRI scans

Interviews

Fighting Fit: tackling Parkinson’s in the workplace

Advances

Apple Watch to detect Parkinson’s symptoms

Is sleepwalking linked to risk of Parkinson’s disease in men?

Stay tuned for series two of the Parkinson’s Life podcast

How Parkinson’s disease could impact the way you see art

{title}

Subscribe

Sign in